Webinar :Join Commodity Ki Paathshala on ‘Volatility in Agriculture commodities Prices- Importance of Price Risk Management and Role of Derivatives Markets’ on March 9, 5pm. Register Now!
you are here: HomeNewsIndia

145 people infected with UK variant of COVID-19 in India: Health Ministry

All these persons have been kept in single room isolation in designated health care facilities by respective state governments, the ministry had said earlier.

January 21, 2021 / 08:34 PM IST

The number of people who have tested positive for the UK variant of COVID-19 in India has climbed to 145, the Union Health Ministry said on Thursday.

All these persons have been kept in single room isolation in designated health care facilities by respective state governments, the ministry had said earlier.

Their close contacts have also been put under quarantine. Comprehensive contact tracing has been initiated for co-travellers, family contacts and others.

Genome sequencing on other specimens is going on, the ministry said.

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The situation is under careful watch and regular advice is being provided to the states for enhanced surveillance, containment, testing and dispatch of samples to INSACOG (Indian SARS-CoV-2 Genomics Consortium) labs.

"The total number of persons found infected with the UK strain of COVID-19 is 145,” the ministry said on Thursday.

The presence of the new UK variant has already been reported by several countries, including Denmark, the Netherlands, Australia, Italy, Sweden, France, Spain, Switzerland, Germany, Canada, Japan, Lebanon and Singapore.

Follow our full coverage of the coronavirus pandemic here.
PTI
first published: Jan 21, 2021 08:34 pm

stay updated

Get Daily News on your Browser
Sections